New MRI study maps rare brain disease in children
NCT ID NCT01325025
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study used powerful MRI scans to track how a rare genetic disease called metachromatic leukodystrophy (MLD) damages the brain's white matter in young children. Researchers studied 29 children aged 1 to 6 years with MLD, along with a control group, to better understand how the disease progresses. The goal was to find new ways to measure the disease that could help select patients for future treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LATE INFANTILE METACHROMATIC LEUKODYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bâtiment Lavoisier - Unité INSERM U 663,Hôpital Necker Enfants Malades
Paris, France
-
Service de Neurologie Pédiatrique, Hôpital Bicêtre
Paris, 94275, France
-
Unité de recherche biomédicale, Neurospin, I2BM / DSV / SAC/ CEA,
Gif-sur-Yvette, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.